GenVault has been awarded U.S. patent #7,142,987 giving GenVault broad rights to dry state sample archiving, using carriers designed to store dried biosamples as discrete, individually addressable aliquots in a predetermined spatial relationship. This patent allows GenVault broad coverage to exclusively develop and market consumables for dry-state biosample storage. This patent also covers the generalized use of hardware for organizing the storage of such dry-state sample aliquots to form sample archives. Finally, the patent covers the generalized use of software to track the location, use-history and the data associated with such individually addressable dry state samples, in the context of organized sample management and archiving.
Further, GenVault has recently acquired the exclusive rights to novel nucleic acid labeling technology. In addition, ten more U.S. patent applications and a similar number of foreign applications have been filed to cover GenVault's unique dry-state biosample management systems and processes.
Specific components of the integrated biosample management systems include:
- room temperature chemistry allowing the elution of double-stranded DNA from the dry-state elements
- biological bar code allowing absolute traceability of the biosamples at all tim
- electronic micro-device tagging of biosamples
- machine stacking devices and procedures allowing very high density storage
New patent applications in process include chemistries for the preservation of proteins in the dry-state.
#7,142,987 hyperlink to: Press News Release from December 19, 2006
exclusive rights hyperlink to: Press article from May 11, 2005
